Washington University School of Medicine
Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.
Programs by Stage
Trial / Program Status
Modality Mix
Indication Coverage
Program Types
Population Tags
Strong-Evidence Records
0 recordsChecked Records With Caveats
5 checked · 0 open checksRandomized double-blind crossover trial of 50% nitrous oxide/50% oxygen versus placebo gas for tinnitus.
Randomized double-blind trial evaluating gabapentin for relief of idiopathic subjective tinnitus.
Completed Phase 1b/2a institution-led trial evaluating oral dantrolene sodium safety, tolerability, and effects on cardinal manifestations of Wolfram syndrome, a syndromic condition with hearing-loss relevance.
Oral zonisamide, a commercially available sulfonamide anticonvulsant/carbonic anhydrase inhibitor, evaluated as a preventive treatment for acute noise-induced hearing loss after firearm training or skull-base surgical drilling.
Withdrawn academic Phase 1/2 prevention study comparing oral zonisamide, methylprednisolone, and no medication around temporary noise exposure.